Intraocular pressure on the first postoperative day as a prognostic indicator in phacoemulsification combined with deep sclerectomy

García-Pérez, J.L.; Rebolleda, Gema; Muñoz‐Negrete, Francisco J.

doi:10.1016/j.jcrs.2008.04.025

Cited by 8 publications

(6 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Day 1 IOP appears to be a significant prognostic factor in combined PKE + NPDS surgery, as shown by Garcia-Pérez et al Day 1 IOP < 9 mmHg was associated with a higher success rate and fewer treatments and goniopunctures [17]. In the present study we had similar results with a complete success rate significantly higher in the subgroup of patients undergoing PKE + NPDS with an IOP < 9 mmHg at Day 1 (p = .02).…”

Section: Discussionsupporting

confidence: 87%

“…However, this was not observed for the PKE + XEN procedure in our study. In NPDS, IOP at Day 1 is an indicator of adequate inner scleral flap dissection and juxtacanalicular trabecular meshwork removal [17], which provides a better result. Although XEN implant provides constant resistance with a steady-state pressure of approximately 6-8 mmHg following an uncomplicated implantation under normal physiologic conditions and without conjunctival resistance to the outflow [9], Day 1 IOP does not seem to be a predictor of long-term outcomes for the XEN, whether it was a standalone or a combined procedure [23].…”

Section: Discussionmentioning

confidence: 99%

“…Secondary outcomes were IOP decrease, number of antiglaucoma medications, surgery duration, complications, number of needling procedures, visual acuity, refraction, and visit number. We conducted a subgroup analysis in order to observe the effect of postoperative IOP at Day 1 < 9 mmHg [17]. The effective operating times of both techniques were calculated using Hospital Manager Bloc software (Softway Medical®, Meyreuil, France).…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Cataract and glaucoma combined surgery: XEN® gel stent versus nonpenetrating deep sclerectomy, a pilot study

et al. 2020

View full text Add to dashboard Cite

Background: To compare the efficacy of phacoemulsification (PKE) combined with nonpenetrating deep sclerectomy (NPDS) with mitomycin C (MMC) versus XEN® gel stent with MMC. Methods: In this nonrandomized, retrospective, comparative, single-center pilot study, 105 consecutive eyes of 75 patients with uncontrolled primary open-angle glaucoma (POAG) and cataract who underwent PKE combined with either XEN implantation (n = 47) or NPDS (n = 58) between May 2013 and November 2018 were included. The primary outcome was complete success at 9 months, which was defined as intraocular pressure (IOP) ≤18, 15 or 12 mmHg without treatment; qualified success was IOP ≤18, 15 or 12 mmHg with antiglaucoma medications. Secondary outcome measures included the number of antiglaucoma medications, visual acuity (VA), and postoperative adverse events. Results: Using the 18 mmHg threshold, complete or qualified success was achieved in 69.6 and 89.1% in the PKE + XEN group, and 63.8 and 89.7% in the PKE + NPDS group (p = .54 and p = .93), respectively, at 9 months. The mean IOP decreased from 20.8 ± 6.8 mmHg to 16.2 ± 2.8 mmHg in the PKE + XEN group (p < .001, 18.9% mean drop), and from 21.5 ± 8.9 mmHg to 14.9 ± 3.9 mmHg in the PKE + NPDS group (p < .001, 25.6% mean drop). Best-corrected VA significantly improved (p < .001) in both groups. The mean number of antiglaucoma medications was significantly reduced from 2.66 ± 1.1 to 0.49 ± 1.0 in the PKE + XEN group (p < .001) and from 2.93 ± 0.9 to 0.69 ± 1.2 in the PKE + NPDS group (p < .001). Conclusions: The XEN stent combined with PKE seemed to be as effective and safe as PKE + NPDS at 9 months in this pilot study.

show abstract

Section: Discussionsupporting

confidence: 87%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Cataract and glaucoma combined surgery: XEN® gel stent versus nonpenetrating deep sclerectomy, a pilot study

et al. 2020

View full text Add to dashboard Cite

show abstract

“…2 Deep sclerectomy (DS) is a nonpenetrating glaucoma surgery (NPGS) technique that has been demonstrated to be as effective as TRAB, but may be less affected by significant postoperative complications. 3 It has been extensively reported that the success rate of DS may be enhanced by the intraoperative use of implants, 4,5 such as purified porcine collagen (Aquaflow), 6,7 reticulated hyaluronic acid (SK-GEL), 8,9 acrylic material (T-Flux), 10 and injectable crosslinked hyaluronic acid (Healaflow; Anteis, Geneva, Switzerland). 11 Intraoperative cross-linked hyaluronic acid was proven to reduce postoperative scarring and adhesions, 12 and to improve the outcome of DS as well as other glaucoma surgical procedures (ie, drainage implants).…”

mentioning

confidence: 99%

Deep Sclerectomy With Mitomycin C and Injectable Cross-linked Hyaluronic Acid Implant: Long-term Results

Bettin

Matteo

Rabiolo

et al. 2016

Journal of Glaucoma

View full text Add to dashboard Cite

show abstract

“…Nonpenetrating deep sclerectomy long-term IOP control [29,135]. Usually, the IOP builds up within a few days to the level of 8-10 mmHg and, in most cases, the AC remains deep.…”

Section: Reviewmentioning

confidence: 99%

Nonpenetrating deep sclerectomy

Al-Obeidan¹

2009

Expert Review of Ophthalmology

View full text Add to dashboard Cite

With the introduction of nonpenetrating deep sclerectomy (NPDS), the safety profile of filtering surgery has dramatically improved owing to the extraocular nature of the procedure that addresses abnormally increased aqueous outflow resistance in Schlemm's canal and the juxtacanalicular trabecular meshwork without entering the anterior chamber. The use of spacemaintaining devices, antimetabolites and neodymium:YAG laser goniopuncture as adjuvant tools in NPDS has improved the long-term results, so that they are comparable with those of trabeculectomy. Therefore, NPDS has become the procedure of choice in the last few years for primary open-angle glaucoma, as well as some other forms of secondary open-angle glaucoma with surgeons who have mastered the procedure. NPDS involves removal of 4 × 4-mm deep scleral flap to deroof Schlemm's canal and expose Descemet's membrane, forming a decompression space or scleral lake. Aqueous humor reaches the scleral lake via the newly created trabeculo-Descemet's membrane to be drained through different routes. The relatively long surgical learning curve remains the main disadvantage of NPDS. In this article, surgical technique, mechanism and routes of filtration, indications, contraindications, complications and results of NPDS will be discussed.

show abstract

Intraocular pressure on the first postoperative day as a prognostic indicator in phacoemulsification combined with deep sclerectomy

Abstract: An IOP of 9 mm Hg or less on the first postoperative day might serve as a positive prognostic indicator in combined phacoemulsification with deep sclerectomy.

Cited by 8 publications

References 16 publications

Cataract and glaucoma combined surgery: XEN® gel stent versus nonpenetrating deep sclerectomy, a pilot study

Cataract and glaucoma combined surgery: XEN® gel stent versus nonpenetrating deep sclerectomy, a pilot study

Deep Sclerectomy With Mitomycin C and Injectable Cross-linked Hyaluronic Acid Implant: Long-term Results

Nonpenetrating deep sclerectomy

Contact Info

Product

Resources

About